Providers/Grant Support
This activity is supported by an educational grant from UCB
Credits Available
- 1.0 AMA PRA Category 1 Credit(s)TM
- 1.0 ANCC Contact Hours
- 1.0 AAPA Category 1 CME Credits
- 1.0 ACPE Contact Hours
- 1.0 CA-BRN Contact Hours for California nurses
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity was developed for pediatricians, primary care physicians, neurologists and epileptologists, nurse practitioners, nurses, physician associates, pharmacists.
Program Overview
The combined developmental and epileptic encephalopathy of Dravet syndrome provides significant diagnostic and treatment challenges. This activity focuses on key characteristics and clinical presentations of Dravet syndrome with the aim of early identification of persons with the syndrome, timely initiation and appropriate use of approved medications, and the need for a multidisciplinary care plan, particularly as individuals transition into adulthood. Dr. Wirrell also provides an overview of investigational disease-modifying therapies.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Summarize key characteristics of Dravet syndrome, its clinical presentation to include signs and symptoms beyond seizures, natural history, burden of disease, and unmet needs.
- Develop an individualized, comprehensive treatment plan for children and adults with Dravet syndrome, using standard-of-care management strategies to alleviate the disease and treatment burden for patients and caregivers.
- Outline data surrounding investigational therapies for Dravet syndrome, including their ability to bridge unmet needs for patients with the disease.
Faculty
Elaine Wirrell, MD
Chair, Child and Adolescent Neurology
Mayo Clinic
Member, Medical Advisory Board
Dravet Syndrome Foundation
Rochester, Minnesota
Accreditation Statement
In support of improving patient care, Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Credit
The Annenberg Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate Credit
The Annenberg Center has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until April 28, 2027. PAs should only claim credit commensurate with the extent of their participation.
Pharmacist Credit
The Annenberg Center designates this knowledge-based activity for a maximum of 1.0 hour. Credit will be provided to NABP CPE Monitor within 45 days after the activity completion.
Nurse Credit
The Annenberg Center designates this education for a maximum of 1.0 American Nurses Credentialing Center (ANCC) contact hour, including 0.5 pharmacology hour.
Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1.0 contact hour. To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
Disclosure Statement
It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All individuals with the potential to impact the content of an accredited education activity are expected to identify and reference off-label product use and disclose relevant financial relationships with ACCME-defined ineligible companies.
The Annenberg Center assesses relevant financial relationships with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant financial relationships that are identified are mitigated by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Laura D. Buch, MSPAS, PA-C
Elaine Wirrell, MD
Consultant: Biocodex, Jazz Pharmaceuticals
Data Safety Monitoring Board: Encoded Therapeutics, GRIN Therapeutics, Neurocrine Biosciences
Additional content planners
The following have no relevant financial relationships to disclose:
Amanda Prather, PA-C (Peer Reviewer)
Mitra Habibi, PharmD (Medical Writer)
Amber Lambert, DNP, FNP-C (Nurse Reviewer)
Annenberg Center for Health Sciences
All staff at the Annenberg Center have no relevant financial relationships to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
Supported Browsers:
Desktop: Newest and last prior version of Google Chrome, Firefox, Safari, and Microsoft Edge
Mobile devices: Newest and last prior version of Safari and Google Chrome
Supported Phones & Tablets:
All devices
Disclosure of Unlabeled Use
The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected]